Migdal Insurance & Financial Holdings’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-270
Closed -$60.6K – 410
2026
Q1
$60.6K Buy
+270
New +$67.3K ﹤0.01% 277
2021
Q2
– Sell
-218
Closed -$42K – 662
2021
Q1
$42K Buy
218
+75
+52% +$15K ﹤0.01% 569
2020
Q4
$30K Sell
143
-5,917
-98% -$1.18M ﹤0.01% 574
2020
Q3
$1.04M Sell
6,060
-5,141
-46% -$949K 0.01% 283
2020
Q2
$2.15M Buy
11,201
+3,431
+44% +$561K 0.03% 172
2020
Q1
$1.14M Sell
7,770
-3,317
-30% -$528K 0.03% 158
2019
Q4
$1.72M Buy
11,087
+1,538
+16% +$222K 0.03% 153
2019
Q3
$1.29M Buy
9,549
+2,857
+43% +$374K 0.03% 218
2019
Q2
$817K Buy
6,692
+1,940
+41% +$215K 0.02% 265
2019
Q1
$494K Buy
4,752
+2,771
+140% +$286K 0.01% 303
2018
Q4
$226K Buy
1,981
+963
+95% +$103K 0.01% 360
2018
Q3
$117K Buy
1,018
+602
+145% +$65.9K ﹤0.01% 574
2018
Q2
$43K Buy
416
+403
+3,100% +$40.8K ﹤0.01% 663
2018
Q1
$1K Buy
+13
New +$1.23K ﹤0.01% 676

Other funds holding RMD

Migdal Insurance & Financial Holdings's RMD Position: Q2 2026 in Review

Migdal Insurance & Financial Holdings sold out of ResMed (RMD) in Q2 2026, closing a stake of 270 shares — an estimated $60.6K sold.

Migdal Insurance & Financial Holdings first reported a position in RMD in Q1 2018 and held it in 14 quarters. The position peaked at $2.15M in Q2 2020. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Migdal Insurance & Financial Holdings reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 270 ResMed shares in Q2 2026, an estimated $60.6K.
  • Migdal Insurance & Financial Holdings first reported a position in ResMed in Q1 2018 and held it in 14 quarters.
  • Migdal Insurance & Financial Holdings's ResMed position peaked at $2.15M in Q2 2020.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2026, filed 10 Aug 2026.